the Stock Exchange of Thailand The Company would like to clarify the net profit for the 9-month periods of the year ending on 30th September 2018 had decreased more than 20% comparing to the same period

August 30th, 2019 To : Managing Director The Stock Exchange of Thailand Re : The acquisition of investment in Nan-Ram Hospital Co.,Ltd. The board of directors of Ramkhamhaeng Public Co.,Ltd. held on

year 2019 To: Managing Director of the Stock Exchange of Thailand The Company would like to clarify the net profit for the 3rd quarter and 9-month periods of the year ending on 30th September 2019 had

the Stock Exchange of Thailand Attachment: The reviewed Q2/2020 Financial Statement Far East Fame Line DDB Public Company Limited would like to submit the reviewed Q2/2020 Financial Statements and the

Microsoft Word - Resolution BD-1-62 _EN_ RE February 27, 2019 Subject: Dividend Payment, The Change of Company’s name, Memorandum of association, Objectives, Articles of association, Company’s seal

Page 1 of 11 No. RJH – SET 4/2018 26 February 2018 Subject : Resolutions of the Board of Directors’ Meeting on acquisition of additional shares in the subsidiaries, dividend payment, and schedule of

the Year as at 31 December 2017 To The President The Stock Exchange of Thailand We, ZEN Corporation Group Public Company Limited (“the Group”), are please to inform you our management discussion and

the Year as at 31 December 2017 (revised) To The President The Stock Exchange of Thailand We, ZEN Corporation Group Public Company Limited (“the Group”), are please to inform you our management

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

subsidiaries Ref. PDI/BK-BS-008/2020 20th February 2020 Re: Management Discussion and Analysis (MD&A) For the year ended December 31, 2019 To: President The Stock Exchange of Thailand Padaeng Industry Public